Flügel, Alexander
28
Apr
/

Flügel, Alexander

Prof. Dr. Alexander Flügel

Institute for Neuroimmunology and Multiple Sclerosis

University Medical Center Göttingen

Georg-August University Göttingen

 

Professor Alexander Flügel took up his current position at the Georg-August University Göttingen as Director of the Institute for Multiple Sclerosis Research and Neuroimmunology in 2008. His main research interest is the mechanisms and factors that allow immune cells to enter the central nervous system, to communicate in this milieu and to influence brain tissue, particularly in relation to multiple sclerosis. He is an expert in applying and optimizing intravital imaging technologies such as two-photon laser scanning microscopy to analyze the autoimmune attack for the CNS in models of experimental autoimmune encephalitis (EAE), an animal model for multiple sclerosis.

16
Apr
/

Heneka, Michael

Michael Heneka, MD

Department of Neurodegenerative Diseases & Gerontopsychiatry/Neurology
University Hospital Bonn

The role of astro- and microglia for neurodegenerative disease has been underestimated.

16
Apr
/

Korn, Thomas

Thomas Korn, MD

Technical University of Munich
Department of Neurology and Neuroimmunology

In our work, we would like to understand how specific properties are imprinted in autoreactive T cells in the peripheral immune compartment that later dictate their effector functions in the central nervous system.

16
Apr
/

Mantovani, Alberto

Prof. Alberto Mantovani, MD

Humanitas University

Alberto Mantovani, MD, is Emeritus Professor of Pathology at the Humanitas University in Milan, and Scientific Director of the Istituto Clinico Humanitas. His attention has been focused on the molecular mechanisms of innate immunity and inflammation. He has contributed to the advancement of knowledge in the field of Immunology formulating new paradigms and identifying new molecules and functions.

For his research activity he has received several national and international awards, such as the Triennial OECI Award from the Organization of the European Cancer Institutes, the Robert Koch Award for his contribution to tumor immunology and immunotherapy, the American-Italian Cancer Foundation (AICF) Prize for Excellence in Medicine and, most recent, the American Association for Cancer Research International Pezcoller Award for Extraordinary Achievement in Cancer Research. The broad impact of his contributions is testified by citations. As of November 2019 he has over 115,900 (Scopus), 108,900 (Web of Science) or 166,900 (Google Scholar) citations and an H-index of 163 (Scopus), 161 (Web of Science) or 187 (Google Scholar).

16
Apr
/

Neher, Jonas

Jonas Neher, PhD

German Center for Neurodegenerative Diseases (DZNE)
University of Tübingen

My primary research interest is the contribution of microglia to neurological disease, with a particular focus on the role of microglia in Alzheimer’s disease and aging as well as their capacity to develop immune memory and its consequences for neuropathology.

16
Apr
/

Rescigno, Maria

Prof. Maria Rescigno

Humanitas University

Mucosal Immunology, host-microbe interactions in the gut-liver-brain axis

16
Apr
/

Sankowski, Roman

Roman Sankowski MD, PhD

Institute of Neuropathology
Department of Neurology and Neurosciences
University Medical Center

Roman Sankowski has studied Medicine at Marburg University and did a PhD at the Feinstein Institute in New York, United States. He is currently doing residency at the Institute for Neuropathology at the University of Freiburg Medical Center. His research topic are myeloid cells of the brain in the health disease.

16
Apr
/

Yong, Wee

Prof. V. Wee Yong

Hotchkiss Brain Institute and
Departments of Clinical Neurosciences and Oncology

Dr. Wee Yong is a Professor at the University of Calgary, Canada. He co-leads the Multiple Sclerosis (MS) NeuroTeam at the university and he directs the provincial Alberta MS Network. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors.  Dr. Yong has published 310 peer-reviewed manuscripts and his research has been translated into Phase III clinical trials in MS and spinal cord injury; he has received national funding for a Phase I/IIa trial in glioblastoma.  His work has been cited over 21,000 times (web of science; h-index of 81). Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada. He has been the President of the International Society of Neuroimmunology (2014-2016) and he continues to co-direct its Global Schools of Neuroimmunology (with Dr. Gianvito Martino). Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada. He is the 2017 Allyn Taylor International Prize in Medicine winner.